
| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| Backblaze, Inc. - Common Stock | BLZE | 15.56 | 15.30 | 936,824 | +10.08 (184.03%) |
| Fate Therapeutics, Inc. - Common Stock | FATE | 3.010 | 2.990 | 582,533 | +1.95 (183.96%) |
| Minerva Neurosciences, Inc - Common Stock | NERV | 4.645 | 4.920 | 22,084 | +3.00 (183.23%) |
| SiTime Corporation - Common Stock | SITM | 573.85 | 615.46 | 164,437 | +370.91 (182.77%) |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 32.92 | 32.43 | 46,764 | +21.23 (181.61%) |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 12.52 | 12.77 | 269,566 | +8.07 (181.35%) |
| Tharimmune, Inc. - Common Stock | THAR | 4.740 | 4.740 | 0 | +3.05 (180.46%) |
| Ligand Pharmaceuticals Incorporated - Common Stock | LGND | 319.03 | 320.42 | 80,448 | +205.27 (180.44%) |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 6.560 | 6.380 | 462,270 | +4.22 (180.34%) |
| InnovAge Holding Corp. - Common Stock | INNV | 11.67 | 12.11 | 87,376 | +7.50 (179.86%) |
| uniQure N.V. - Ordinary Shares | QURE | 40.03 | 41.36 | 390,869 | +25.72 (179.73%) |
| Definium Therapeutics, Inc. - Common Shares | DFTX | 43.00 | 44.33 | 675,270 | +27.62 (179.58%) |
| UroGen Pharma Ltd. - Ordinary Shares | URGN | 37.67 | 37.41 | 186,110 | +24.18 (179.24%) |
| Astronics Corporation - Common Stock | ATRO | 71.00 | 71.79 | 124,160 | +45.56 (179.06%) |
| Applied Materials | AMAT | 531.89 | 592.79 | 4,750,086 | +341.11 (178.80%) |
| Electrovaya Inc. - Common Shares | ELVA | 8.815 | 9.670 | 197,922 | +5.63 (177.20%) |
| NETCLASS TECHNOLOGY INC - Class A Ordinary Shares | NTCL | 4.125 | 4.620 | 23,072 | +2.63 (176.85%) |
| Tetra Technologies, Inc. Common Stock | TTI | 8.940 | 9.400 | 247,601 | +5.70 (175.93%) |
| EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | EDAP | 4.320 | 4.320 | 0 | +2.75 (175.16%) |
| Onto Innovation Inc. Common Stock | ONTO | 271.07 | 303.86 | 310,176 | +172.38 (174.65%) |
| Immunome, Inc. - Common Stock | IMNM | 23.79 | 23.90 | 133,873 | +15.10 (173.76%) |
| Sterling Infrastructure, Inc. - Common Stock | STRL | 648.05 | 717.11 | 167,033 | +411.05 (173.44%) |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 26.70 | 26.45 | 62,409 | +16.91 (172.73%) |
| Xometry, Inc. - Class A Common Stock | XMTR | 91.75 | 94.30 | 98,914 | +58.06 (172.32%) |
| Savara, Inc. - Common Stock | SVRA | 6.365 | 6.200 | 343,798 | +4.03 (172.01%) |
| Kymera Therapeutics, Inc. - Common Stock | KYMR | 117.89 | 114.76 | 171,048 | +74.08 (169.08%) |
| Amylyx Pharmaceuticals, Inc. - Common Stock | AMLX | 18.17 | 17.97 | 183,459 | +11.41 (168.79%) |
| Belite Bio, Inc - American Depositary Shares | BLTE | 157.35 | 154.02 | 79,036 | +98.72 (168.38%) |
| Mercurity Fintech Holding Inc. - American Ordinary Shares | MFH | 11.35 | 11.35 | 0 | +7.12 (168.32%) |
| Maze Therapeutics, Inc. - Common Stock | MAZE | 32.52 | 32.35 | 72,486 | +20.40 (168.28%) |